ONC

BeOne Medicines Ltd. - Sponsored ADR (ONC) has been upgraded to a Zacks Rank #1 (Strong Buy) rating, primarily driven by upward trends in earnings estimates. Over the past three months, the Zacks Consensus Estimate for the company has increased 53.4%. The upgrade positions the stock in the top 5% of Zacks-covered stocks, suggesting potential for near-term price appreciation based on improving earnings outlook.